SEC Form 3 · accession 0001144204-18-054561
Checkpoint Therapeutics, Inc. · CKPT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Christian Bechon
Director
Period of report
Oct 15, 2018
Accepted (ET)
Oct 19, 2018 · 4:31 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001651407
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock (Restricted)F1 | holding | — | — | — | 50,000 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The 50,000 shares are restricted common stock, with one-third of the 50,000 shares vesting on October 15, 2021, one-third on October 15, 2022 and one-third on October 15, 2023.